Provided By PR Newswire
Last update: Sep 22, 2023
NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. (NASDAQ: PYXS) concerning possible breaches of fiduciary duty. To obtain additional information, go to:
Read more at prnewswire.com1.73
-1.64 (-48.66%)
Find more stocks in the Stock Screener


